Abstract. It has been suggested that intramyocellular lipids (IMCLs) may serve as biomarkers of insulin resistance and mitochondrial dysfunction. Using a hind-limb mouse model of burn trauma, we tested the hypothesis that severe localized burn trauma involving 5% of the total body surface area causes a local increase in IMCLs in the leg skeletal muscle. We quantified IMCLs from ex vivo intact tissue specimens using High-Resolution Magic Angle Spinning (HRMAS) 1 H NMR and characterized the accompanying gene expression patterns in burned versus control skeletal muscle specimens. We also quantified plasma-free fatty acids (FFAs) in burn versus control mice. Our results from HRMAS 1 H NMR measurements indicated that IMCL levels were significantly increased in mice exposed to burn trauma. Furthermore, plasma FFA levels were also significantly increased, and gene expression of Glut4, insulin receptor substrate 1 (IRS1), glycolytic genes, and PGC-1ß was downregulated in these mice. Backward stepwise multiple linear regression analysis demonstrated that IMCL levels correlated significantly with FFA levels, which were a significant predictor of IRS1 and PGC-1ß gene expression. We conclude from these findings that IMCLs can serve as metabolic biomarkers in burn trauma and that FFAs and IMCLs may signal altered metabolic gene expression. This signaling may result in the observed burn-induced insulin resistance and skeletal muscle mitochondrial dysfunction.
Introduction
Severe burns carry high rates of mortality and morbidity (1, 2) , and are complicated by the associated development of insulin resistance (3, 4) and mitochondrial dysfunction (5) . Treatment of patients suffering from burn trauma can also be complicated by organ dysfunction and the late development of infection (1, 2) . For these reasons, the pathophysiology of burn trauma remains an area of intense study (2) . It is believed that early administration of appropriate therapeutic factors may be useful in limiting post-burn metabolic dysfunction. In order to evaluate the effectiveness of such factors, metabolic biomarkers are required.
In addition to its association with burn trauma, insulin resistance is also frequently observed in various metabolic diseases, including obesity, dyslipidemia, arterial hypertension, and type 2 diabetes. Skeletal muscle wasting in insulin-resistant burn patients has been documented and develops due to a lack of anabolic effects, as well as enhanced gluconeogenesis and protein catabolism (6, 7) in the burned skeletal tissue. Although the molecular mechanisms underlying abnormal insulin function in burn victims have not been elucidated, there is increasing evidence that plasma-free fatty acids (FFAs) may play a role in inducing insulin resistance (8) . Because fatty acid metabolism and glucose levels are closely linked, aberrations in FFA levels, such as through accumulation of lipids or triglycerides in the muscle, may lead to insulin resistance (9) .
Aberrations in the peroxisome proliferator-activated receptor coactivator 1 (PPARγ coactivator-1 or PGC-1) family of coactivators (10, 11) are also related to metabolic abnormalities. PGC-1α and PGC-1ß are close homologs and share extensive sequence identity (12) . In general, PGC-1 coactivators play a critical role in the maintenance of glucose, lipid and energy homeostasis, and are likely to be involved in pathogenic conditions such as neurodegeneration, cardiomyopathy, obesity, diabetes (13) , and potentially, burn injury. 1 H NMR spectroscopy is a useful method for measuring intramyocellular lipid (IMCL) levels (14, 15) . The resonances from the methyl and methylene protons of the triglyceride acyl chains appear between 1.0 and 1.6 ppm in the proton NMR spectra. Boesch et al and Schick et al independently reported that in vivo proton NMR spectroscopy detects two sets of resonances from fatty acyl chains within muscle, shifted 0.2 ppm apart (16, 17) . These investigators suggested that these signals originate from two distinct adipocyte and intramyocellular compartments, which has been further verified by other studies. It has also been suggested that proton NMR spectroscopy may serve as a useful method for monitoring triglyceride levels in adipose or metabolically active muscle cells. Although IMCL levels depend on the muscle type, and the age and gender of the patient (18, 19) , nevertheless, studies indicate that IMCLs may serve as useful indices of insulin resistance/metabolic abnormality in nondiabetic nonobese humans (20, 21) . Furthermore, elevated IMCLs have been detected in obese and/or type 2 diabetic patients, where increased IMCL levels are due to impaired insulin-stimulated glucose uptake (22) (23) (24) .
In addition to NMR spectroscopy, which measures biomarkers in intact systems, the development of highthroughput microarray systems capable of simultaneously measuring the expression of thousands of genes has greatly advanced our ability to detect biomarkers. By exploring the expression of certain organ-specific candidate genes, the biological relevance of NMR data can be validated in experiments examining the same specimen. Combining NMR and microarray data provides an opportunity to cross-validate such data (5) .
Here, we measured levels of IMCLs visible by HighResolution Magic Angle Spinning (HRMAS) 1 H NMR spectroscopy of intact proximal skeletal muscle tissue samples following burn trauma in mice. We found that increased IMCL levels were a metabolic biomarker for insulin resistance. Furthermore, increased levels of FFAs in the plasma of mice experiencing burn trauma were associated with increased IMCL levels. These results enabled us to propose a molecular mechanism governing burn-induced insulin resistance; plasma FFA levels increase as a result of burn trauma and cause an increase in IMCL levels. This induces insulin resistance through downregulation of the glucose transport system (Glut4) and the insulin receptor substrate 1 (IRS1), where downregulation may occur through the posttranscriptional coactivator PGC-1ß.
Materials and methods
Experimental animals. Male, 6-wk-old CD1 mice weighing 20-25 g were purchased from Charles River Laboratory (Boston, MA). The animals were maintained on a regular light-dark cycle (lights on from 8:00 to 20:00 h) at an ambient temperature of 22±1˚C, and had free access to food and water. All animal experiments were approved by the Subcommittee on Research Animal Care of the Massachusetts General Hospital, Boston, MA.
Hind limb burn model. Mice were anesthetized by intraperitoneal (i.p.) injection of 40 mg/kg pentobarbital sodium and were randomized into burn or control groups. The left hind limb of all mice in both groups (control and burn) was shaved, and each mouse in the burn group was subjected to a nonlethal scald injury of 3-5% total body surface area (TBSA) by immersion of the left hind limb in 90˚C water for 3 sec as previously described (25) . The total surface area of each mouse was calculated using Meeh's formula: A = k x W 2/3 where A is the surface area in cm 2 ; k is the proportionality constant 12.3; and W is the weight in grams. Mice were resuscitated with 2 ml of 0.9% saline i.p. The gastrocnemius muscle was excised from the hind limbs of both control and treated mice, and was immersed in 1 ml TRIzol ® (Gibco BRL, Invitrogen, Carlsbad, CA) for RNA extraction at 6 h, 12 h, 1 day, and 3 days post burn (n=3 measurements at each time point). After injury, the animals were given analgesia in the form of buprenorphine 0.05-0.1 mg/kg SQ, as needed.
HRMAS
1 H NMR spectroscopy of skeletal muscle tissue after burn trauma. Animals were studied with HRMAS 1 H NMR spectroscopy before and at 6, 24 and 72 h after burn trauma. In burn mice, the skeletal muscle tissue underlying the hind limb burn site was harvested, immediately frozen in liquid nitrogen, and stored at approximately -80˚C. The muscle tissue at the same site from unburned animals served as controls. Three mice per each category were investigated. HRMAS 1 H NMR spectroscopy experiments of muscle tissue were performed on a Bruker Bio-Spin Avance NMR spectrometer (proton frequency at 600.13 MHz, 89 mm Vertical Bore) using a 4-mm triple resonance ( 1 H, 13 C, 2 H) HRMAS probe (Bruker, Billerica, MA). The temperature was maintained at 4˚C by a BTO-2000 thermocouple unit in combination with a magic angle spinning (MAS) pneumatic unit (Bruker). The MAS speed was stabilized at 4.0±0.001 kHz by a MAS speed controller. The 1 H NMR spectra were acquired for all samples using a Carr-Purcell-Meiboom-Gill (CPMG) spin echo pulse sequence, [90˚-(τ-180˚-τ) n -acquisition], with an inter-pulse delay (τ) of 250 μsec. Hard 90˚ (8 μsec) and 180˚ (16 μsec) were employed. The relaxation delay was set to 2 sec, and spectra were collected both with and without water suppression. The transverse relaxation time (T 2 ) was measured using the same CPMG pulse sequence by varying n from 0 to 520. Free induction decay (FID) signals were acquired with 8k points, 600 msec acquisition time, 8 dummy scans and 128 scans. HRMAS 1 H NMR spectra were analyzed using the MestRe-C NMR software package (Mestrelab Research, Santiago de Compostela, Spain, www.mestrec.com). FIDs were zero-filled to 16k points and apodized with exponential multiplication (1 Hz) before Fourier transformation. The spectra were then manually phased and corrected for baseline broad features (Whittaker smoother, smooth factor 10,000). The Levenberg-Marquardt algorithm was used to leastsquares-fit a model of mixed Gaussian/Lorentzian functions to the data.
The (CH 2 ) n-2 peak at 1.32 ppm was selected for quantification of IMCL levels. Because the sample was spun at the magic angle, and the sample was much smaller (25 μl) and more homogeneous (reduced bulk magnetic susceptibility effects) than the typical voxel size (1 ml) of in vivo 1 H MRS, no chemical shift difference was observed between IMCL and extramyocellular lipids (EMCL). The small size of the muscle biopsies and the fact that the samples were collected from the most myocellular part of the muscle suggest that the main contribution to the (CH 2 ) n-2 peak was from IMCLs.
RNA extraction. At 6, 24 and 72 h post burn, 3 burn and 3 control mice were anesthetized by i.p. injection of 40 mg/kg pentobarbital, and the gastrocnemius was excised. All mice were then administered a lethal dose of pentobarbital (200 mg/ kg i.p.), and the gastrocnemius muscle was immediately immersed in 1 ml TRIzol (Gibco BRL) for RNA isolation. The muscle was homogenized for 60 sec using a Brinkmann Polytron PT 3000 homogenizer (Brinkmann Instruments, Westbury, NY) before extraction of total RNA. Chloroform (200 μl) was added to the homogenized muscle and mixed by inverting the tube for 15 sec. After centrifugation at 12,000 x g for 15 min, the upper aqueous phase was collected and precipitated by adding 500 μl isopropanol. Further centrifugation at 12,000 x g for 10 min separated the RNA pellet, which was then washed with 500 μl 70% ethanol and centrifuged at 7,500 x g for 5 min prior to air-drying. The pellet was resuspended in 100 μl DEPC-H 2 0. An RNeasy Kit (Qiagen, Valencia, CA) was used to purify the RNA according to the manufacturer's protocol. Purified RNA was quantified by UV absorbance at 260 and 280 nm and stored at -70˚C for DNA microarray analysis.
Microarray hybridization. Biotinylated cRNA was generated with 10 μg of total cellular RNA according to the protocol outlined by Affymetrix Inc. (Santa Clara, CA). cRNA was hybridized onto MOE430A oligonucleotide arrays (Affymetrix), stained, washed, and scanned according to Affymetrix protocol.
Genomic data analysis. The scanned images of cRNA hybridization were converted to cell intensity files (.CEL files) with the Microarray suite 5.0 (MAS, Affymetrix). The data were scaled to a target intensity of 500, and for each time point all possible pairwise array comparisons of the replicates to control mice were performed (i.e., four combinations when the two arrays from each time point were compared to the two arrays from control mice), using a MAS 5.0 change call algorithm. Probe sets that had a signal value difference >100 and in which both samples were present were scored as differentially modulated when i) the number of change calls in the same direction were at least 3, 4, and 6 when the number of comparisons were 4, 6, and 9, respectively; and ii) the other comparisons were unchanged. Such scoring was to partially compensate for biological stochasticity and technical variation. Based on the ratios of 100 genes determined to be invariant in most of the conditions tested (Affymetrix) in the hind limb burn and control animals, an additional constraint of a minimum ratio of 1.65 was applied to control the known false positives at 5% hind limb.
Electron microscopy analysis. Briefly, hind leg skeletal muscle of the control and burn mice was dissected and fixed in 2% glutaraldehyde in 0.1 M cacodylate buffer overnight at 4˚C.
The tissue was postfixed and stained with 1% osmium tetroxide in 0.1 M cacodylate buffer, incubated with uranyl acetate, and dehydrated with ethanol. The tissues were subsequently rinsed with propylene oxide and embedded using Embed 812. Longitudinal and thin cross sections (60 nm) were counterstained with uranyl acetate and lead citrate and photographed on a Jeol 1200-Ex transmission electron microscope.
Plasma FFA assay. Blood was drawn by heart puncture at the time of sacrifice, and the plasma FFA level was measured by using the calorimetric FFA assay kit that uses acylation of coenzyme A (NEFA C; Wako Chemicals USA, Inc., Richmond, VA).
Statistical analysis. The Kolmogorov-Smirnov and Levene's tests were used to assess the normality of the variables and homogeneity of variances, respectively. Differences in ratios of IMCL levels (1.4 ppm) to total creatine (1.32 ppm) and T 2 values between time groups were evaluated by using the nonparametric Kruskal-Wallis test. Analysis of variance (ANOVA) was also performed by using parametric and nonparametric methods to ensure that the differences or lack of differences between groups were consistent.
The Pearson product-moment correlation coefficient (R) was calculated to assess the correlation between the PGC-1ß or IRS1 gene expression levels and levels of IMCLs or FFAs. Independent predictors of PGC-1 and IRS expression were analyzed with backward stepwise multiple linear regression with p<0.05 required for variables to be retained in the model. The coefficient of determination (adjusted R 2 ) was used to measure model fit.
Statistical analysis was conducted using SPSS, version 12.0 (SPSS, Chicago, IL), and a two-tailed α level of 0.05 was used as the criterion for statistical significance for all comparisons.
Results
IMCLs as detected by NMR rise in proximal skeletal muscle and correlate significantly with the rise in plasma FFAs. Fig. 1 shows representative 1 H-NMR spectra acquired from normal and burned mice, and illustrates a notable post-burn rise in IMCLs. Quantitative results of these measurements (Table I) demonstrate a significant rise in ICMLs at 6, 24 and 72 h post burn. The T 2 of IMCLs did not change significantly with burn. Electron microscopy (EM) results also demonstrated that IMCLs accumulated post burn (Fig. 2) . In addition, plasma levels of FFAs correlated significantly with IMCLs (R=0.965; p=0.035), as shown in Fig. 3 .
Burn injury downregulates the expression of Glut4, IRS1 and PGC-1ß.
In our transcriptome studies, we compared the expression of all genes that might lead to metabolic dysfunction in skeletal muscle after burn. Here, we show the differential expression of certain metabolic genes at 3 time points following a localized, but severe, hind limb burn (Table II) . We observed downregulation of all of the genes shown post burn. IRS1 expression was downregulated at all 3 time points post burn; however, Glut4 expression was downregulated only at 72 h post burn. Finally, the expression of PGC-1ß was downregulated at 6 h and reached a minimum at 24 h which was maintained at 72 h post burn. (Fig. 4) . Table III shows the results of our backward stepwise multiple linear regression and correlation analyses. FFA levels correlated with both IRS1 and PGC-1ß expression, whereas the IMCL level correlated only with PGC-1ß. The FFA level was a significant predictor of PGC-1ß (p=0.097, adjusted R 2 =0.723) or IRS1 (p=0.038, adjusted R 2 =0.887) expression, but IMCL was not a significant predictor of either PGC-1ß (p=0.562) or IRS1 (p=0.468) expression. Nevertheless, our correlation analysis showed that IMCL and FFA levels have a significant positive relationship (Fig. 3) . ---------------------------------------------------------------------------------------------------- n, number of mice studied; IMCLs, intramyocellular lipids normalized to the creatine peak; T 2 , transverse relaxation time indicating nonsignificant mobility of IMCLs after burn; a values are the means ± standard errors; b p-values for comparisons between burned and normal mice obtained with the Games Howell test for IMCLs (the difference between 24 and 72 h was also significant; p=0.007); and c NS, nonsignificant difference between burned and normal mice obtained using the Tukeys test for T 2 .
Plasma FFA level is a significant predictor of IRS1 and/or PGC-1ß gene expression

-----------------------------------------------------------------------------------------------------Normal (n=6) 6 h post burn (n=6) 24 h post burn (n=3) 72 h post burn (n=3) -----------------------------------------------------------------------------------------------------
- 
Discussion
The present study demonstrates that burn trauma results in: i) a significant increase of IMCLs or intracellular triglyceride stores in proximal skeletal muscle; ii) a rise in plasma FFAs; and iii) a downregulation of IRS1, Glut4 and PGC-1ß mRNA levels. The downregulation of IRS1 and PGC-1ß in skeletal muscle, which parallels the rise of plasma FFA levels, may be an upstream regulatory mechanism involving insulin resistance and mitochondrial uncoupling, leading to apoptosis Table II . Differential expression of metabolic genes at 6, 24 and 72 h post burn.
-----------------------------------------------------------------------------------------------------GenBank
Name of gene Gene symbol GO biological 6 h 24 h 72 h accession no. 
process -----------------------------------------------------------------------------------------------------
Values are the relative expression intensity of the burn versus the control animals. Gene annotations for biological processes are from the Gene Ontology Consortium and the Ingenuity database. (/) not differentially expressed compared to the normal controls. Table III . Correlations between plasma FFAs, IMCLs, and IRS1 and PGC-1ß gene expression 6, 24 and 72 h post burn. 
-----------------------------------------------------------------------------------------------------
FFA, plasma-free fatty acids; IRS1, insulin receptor substrate 1; IMCL, intramyocellular lipids by NMR; PGC-1ß, peroxisome proliferator-activated receptor coactivator 1 (PPARγ coactivator-1 or PGC-1ß).
- ----------------------------------------------- as observed in burned skeletal muscle (4, 26) . Such a process may occur in response to the increased levels of reactive oxygen species (ROS) (11) and cytokines (i.e., TNFα observed in systemic burn) (3). Our findings suggest that IMCLs in skeletal muscle could serve as metabolic biomarkers related to inflammation, diabetes and obesity.
Here, we applied HRMAS 1 H NMR to intact muscle samples from animals subjected to burn trauma in order to identify at high-resolution concomitant metabolic and molecular aberrations associated with insulin resistance and metabolic dysfunction. These changes might also reflect mitochondrial dysfunction, as some of the genes downregulated in response to burn trauma encode mitochondrialdependent metabolic functions (5) . The strength of HRMAS is that it allows dual investigation of metabolic and molecular changes since the same specimens studied with HRMAS can subsequently be used for transcriptome studies (4) . Compared with the use of conventional high-resolution in vitro NMR to examine tissue extracts exposed to burn trauma (27) , ex vivo HRMAS NMR of intact tissue provides superior biochemical information, with simplified sample preparation and a better approximation of the in vivo state (4) . To this end, this technique is increasingly being used to investigate overt cellular diseases (4, (28) (29) (30) (31) (32) (33) .
In this, as well as in previous studies, increased IMCL levels are associated with insulin resistance (15), a major metabolic dysfunction that can develop as a result of severe burn trauma (3, 6) . The cytoplasmic localization of IMCLs as indicated by EM does not appear to change after severe burn, as indicated by a lack of change in ICML T 2 levels post burn (Table II) . Thus, these IMCLs or triglycerides are stored in the cytoplasm and appear to be metabolically inert, contributing to declining ATP synthesis (5) . Previous measurements of muscle triglyceride content by biopsy (34) and IMCL content by 1 H NMR spectroscopy (20, 35) showed a strong relationship between intramuscular fat content and insulin resistance.
Although increased fatty acid delivery from lipolysis could also produce the observed IMCL increase, FFA concentrations are highly variable in burn patients (36) . Also, impaired lipoprotein and polyunsaturated fatty acid metabolism occurs in the early post-burn period (37) , suggesting their involvement in subsequent healing and immune responses. Previous genomic data alternatively suggest that the increased IMCL level could be the result of decreased mitochondrial oxidative capacity (5), in agreement with gene expression data in human diabetes (38) . It has also been reported that increased IMCLs are associated with insulin resistance in type 2 diabetes (39), suggesting a role for IMCL levels in reducing mitochondrial oxidation and phosphorylation.
It has also been proposed that burn-induced insulin resistance may be related to the development of 'ectopic' fat stores. Triglyceride stores develop in sites such as the liver and muscle cells, due to increased FFA delivery following catecholamine-induced lipolysis, decreased ß-oxidation within muscle, and decreased hepatic secretion of fats. These increases in intracellular triglyceride levels may contribute to the observed alterations in insulin signaling (40) . In accordance with this, the IMCL accumulation detected by NMR in this study qualifies as a biomarker of altered insulin resistance and signaling in burn trauma.
One major finding of our experiments is that a rise in IMCLs correlates positively with plasma FFAs, which also rise in many insulin-resistant states, including not only burn trauma but also type 2 diabetes and obesity (41) (42) (43) . FFAs are also a significant predictor of IRS1 and PGC-1ß gene expression. Our results corroborate what has been previously reported for insulin resistance in human skeletal muscle, that is, that increased plasma FFAs induce insulin resistance through inhibition of glucose transport activity, which may be a consequence of decreased IRS1 activity (43) . Based on our study, the expression profile of the IRS1 insulin substrate, which was significantly reduced by 6 h post burn and continued to decrease thereafter, may suggest that FFAs affect IRS1 expression, which in turn affects Glut4 expression and glucose transport by 72 h post burn. This observed decrease in glucose transport is in agreement with several previous studies (44) (45) (46) (47) , including a study performed in rats where alterations in post-receptor insulin signaling were implicated as one mechanism for post-burn insulin resistance (3). We found that the expression of PGC-1ß was also affected by burn (Table II) . Although our results do not indicate whether IRS1 expression affects PGC-1ß or vice versa, because PGC-1ß is a transcriptional co-activator, we postulate that it acts as an upstream regulator of metabolic genes, including IRS1 (11) . If this is so, then PGC-1ß may also contribute to burn-induced insulin resistance. It may be, that in burn, ROS affect PGC-1ß which affects a myriad of other genes important in metabolism and insulin resistance. Although further studies are needed to examine this hypothesis, nevertheless, our present study strongly implicates IMCLs as metabolic biomarkers of glucose homeostasis and fatty acid metabolism in pathological states such as burn.
The transcriptome findings presented here suggest that burn trauma results in reduced IRS1 and PGC-1ß gene expression by skeletal muscle nuclei. This was validated by NMR spectroscopy, which uncovered increased IMCLs or Figure 5 . Proposed molecular mechanism of insulin resistance in skeletal muscle after burn. In this scheme, FFAs influence the accumulation of IMCLs and trigger PGC-1ß which is an upstream regulator of IRS1. IRS1 in turn downregulates Glut4 and glucose transport, thus conferring insulin resistance in skeletal muscle. FFA, plasma-free fatty acids; IRS1, insulin receptor substrate 1; IMCL, intramyocellular lipid levels obtained by NMR; PGC-1ß, peroxisome proliferator-activated receptor coactivator 1 (PPARγ coactivator-1) or PGC-1ß.
tryglyceride stores in the post-burn skeletal muscle cytoplasm. These results can be explained by the downregulation of genes involved in ß-oxidation and an absence of ATP synthesis, which lead to the mitochondrial dysfunction that underlies skeletal muscle wasting and the general cachexia of burn pathophysiology (5) . It has been shown that PGC-1ß (like PGC1-α) increases mitochondrial biogenesis and respiration when expressed in muscle cells, implicating a role for this gene in mitochondrial metabolism (48) . Recently, PGC-1ß was also recognized as an activator of uncoupling proteins, which greatly reduce mitochondrial ROS production (13) . Thus, we propose that the downregulation of PGC-1ß observed in this study leaves the muscle unprotected against the harmful oxidative damage of ROS, which is probably exacerbated by burn. Combining these various results, we propose a potential molecular mechanism for burn-induced skeletal muscle insulin resistance (Fig. 5) .
Finally, we believe that our findings may be clinically relevant in molecular medicine, since a) both FFAs and IMCLs can be measured clinically using non-invasive and non-irradiating procedures; b) the activity of PGC-1ß may be induced; and c) PGC-1ß agonists may alleviate post-burn insulin resistance (49) and prevent burn-induced damage in remote organs (50) . These findings open the door to a better understanding of molecular and metabolic processes attendant to local burn trauma and/or other traumatic situations.
